Get the Stockscreener App
0.00
100.00%
-4.74
After Hours:
4.83
4.83
+
Tharimmune Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
See More
Previous Close:
$4.74
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$187.37M
Revenue:
-
Net Income/Loss:
$-9.32M
P/E Ratio:
0.00
EPS:
-12.7107
Net Cash Flow:
$-7.30M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$9.08
Tharimmune Inc Stock (THAR) Company Profile
Name
Tharimmune Inc
Sector
Industry
Phone
302-743-2995
Address
1200 ROUTE 22 EAST, BRIDGEWATER
Compare THAR vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
0.00 | 187.37M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tharimmune Inc Stock (THAR) Latest News
Canton Strategic Holdings CEO joins Canton Foundation board By Investing.com - Investing.com Canada
Canton Strategic Holdings CEO joins Canton Foundation board - Investing.com
Canton Strategic Holdings Inc enters amended sales agreement with Clear Street and Virtu AmericasSEC filing - marketscreener.com
Canton Strategic Holdings amends stock sales agreement, adds Virtu Americas as agent - Investing.com
Canton Strategic Holdings, Inc. chairman and CEO Mark Wendland elected to Canton Foundation board - marketscreener.com
Canton Strategic Holdings, Inc. Chairman and CEO Mark Wendland Elected to Canton Foundation Board - marketscreener.com
Volume Recap: Is Tharimmune Inc stock undervalued right nowWeekly Risk Summary & Fast Gain Swing Alerts - baoquankhu1.vn
CNTN Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
THAR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
THAR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Does Tharimmune Inc. offer margin of safety2025 Key Highlights & Free Daily Entry Point Trade Alerts - mfd.ru
Tharimmune (NASDAQ:THAR) Trading Up 3.8%Time to Buy? - MarketBeat
Aug Retail: Is Tharimmune Inc a stock for growth or value investorsWeekly Trade Review & Risk Controlled Swing Alerts - baoquankhu1.vn
Buybacks Report: What are analysts price targets for Tharimmune IncIPO Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
Death Cross: Is Tharimmune Inc a cyclical or defensive stockM&A Rumor & Weekly High Return Stock Opportunities - baoquankhu1.vn
Tharimmune Rebrands as Canton Strategic Holdings, Updates Ticker - The Globe and Mail
Tharimmune Rebrands as Canton Strategic, Ticker CNTN - National Today
Canton Strategic Holdings (NASDAQ: CNTN) rebrands and highlights $545M crypto strategy - Stock Titan
Is Canton’s price set to explode amid Tharimmune’s rebrand? - Bitget
Tharimmune rebrands to Canton Strategic Holdings with new NASDAQ ticker - Investing.com Australia
Tharimmune rebrands as Canton Strategic Holdings with new ticker CNTN By Investing.com - Investing.com Nigeria
Tharimmune rebrands to Canton Strategic Holdings with new NASDAQ ticker By Investing.com - Investing.com South Africa
Tharimmune rebrands as Canton Strategic Holdings with new ticker CNTN - Investing.com
Tharimmune Inc rebrands to Canton Strategic Holdings - marketscreener.com
Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy - marketscreener.com
Is Tharimmune Inc. a potential multi baggerQuarterly Portfolio Summary & Long-Term Growth Plans - mfd.ru
Pharma News: Is VNOM a good stock for dollar cost averagingPortfolio Gains Summary & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Investment Report: Is Tharimmune Inc a potential multi baggerJuly 2025 Snapshot & Entry Point Confirmation Signals - baoquankhu1.vn
Will Tharimmune Inc. benefit from geopolitical trendsWeekly Stock Summary & Daily Stock Trend Watchlist - mfd.ru
Does Tharimmune Inc. have strong EBITDA marginsJuly 2025 Momentum & Stepwise Entry and Exit Trade Signals - mfd.ru
Is Tharimmune Inc. stock showing strong momentumJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - mfd.ru
Tharimmune appoints new chairman and COO to advance digital asset strategy - Investing.com Canada
Tharimmune Elects CEO Mark Wendland as Chair, Names Angela Radkowski as COO - marketscreener.com
Tharimmune strengthens leadership and governance for Canton strategy - TipRanks
Tharimmune appoints new chairman and COO to advance digital asset strategy By Investing.com - Investing.com South Africa
Ex-DRW and Citadel exec tapped to run Tharimmune's Canton push - Stock Titan
Is Tharimmune Inc a cyclical or defensive stockPortfolio Growth Summary & Community Verified Watchlist Alerts - baoquankhu1.vn
Tharimmune Closes $545M Private Placement for Blockchain Strategy - MSN
Winners Losers: Does Tharimmune Inc offer margin of safetyJuly 2025 EndofMonth & Capital Efficient Trade Techniques - baoquankhu1.vn
Aug Fed Impact: What are analysts price targets for Affinity Bancshares IncStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Tharimmune adds former CFTC commissioner and DRW executive to board By Investing.com - Investing.com Nigeria
Tharimmune Adds Jill Sommers And William Wiley To Board As Canton Network Strategy Expands - Pulse 2.0
Risk Off: Is Tharimmune Inc a cyclical or defensive stockJuly 2025 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Tharimmune Appoints Jill Sommers and William Wiley To Board - citybiz
Tharimmune Adds New Directors to Support Digital Strategy - TipRanks
Tharimmune adds former CFTC commissioner and DRW executive to board - Investing.com
Ex-CFTC regulator joins Tharimmune board amid blockchain finance shift - stocktitan.net
Canton Treasury Company Tharimmune adds former CFTC commissioner and DRW partner to its board of directors - Bitget
Loss Report: Is Tharimmune Inc a cyclical or defensive stockGDP Growth & Smart Investment Allocation Tips - baoquankhu1.vn
Tharimmune Shareholders Approve Directors, Warrant-Linked Share Issuances and 7M Share Plan Boost - MarketBeat
Tharimmune Inc Stock (THAR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
6.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):